Report : North America Healthcare Contract Research Organizations (CRO) Services Market Forecast to 2027 - COVID-19 Impact and Regional Analysis byService Type (Early Phase Development, Laboratory Services, Consulting Services, Clinical Research Services); Therapeutic Indication (Oncology, Infectious Diseases, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, Others); End User (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies, Others (Academic Institutes), and Country

According to our new market research study on “North America Healthcare Contract Research Organizations (CRO) Services Market to 2027 – Regional Analysis and Forecast – by Service Type, Therapeutic Indication and End-User” the market is expected to reach US$ 40,863.26 million by 2027 from US$ 19,498.79 million in 2019; it is estimated to grow at a CAGR of 9.9% from 2020 to 2027. The report provides trends prevailing in the North America healthcare contract research organizations (CRO) services market and the factors driving the market growth along with those hindering it.

Based on service type, the healthcare contract research organizations (CRO) services market is further segmented into early phase development, laboratory services, consulting services, and clinical research services. Early phase development market is further categorized into discovery studies, chemistry, marketing & manufacturing, and preclinical market. The laboratory services segment is further sub segmented as bio-analytical testing and analytical testing. The clinical research services segment is further bifurcated into phase I, phase II, phase III, and phase IV. In 2019, the clinical research segment accounted for the largest share of the market. Growth of this segment is attributed to the increasing clinical trials and growing R&D investment.

The growth of the North America healthcare contract research organizations (CRO) services market is mainly attributed as growing number of clinical trials and increasing expenditure in R&D and outsourcing activities in the country. However, the stringent regulations for approval of drugs is the major factor hindering the market growth in North America.

A few of the leading companies operating in the North America healthcare contract research organizations (CRO) services market are Charles River Laboratories, Inc., IQVIA INC, Laboratory Corporation of America Holdings (Covance), Parexel International Corporation, PRA Health Sciences, Syneos Health, Medpace, and PPD Inc.

      North America Healthcare Contract Research Organizations (CRO) Services Market, By Country, 2019 (%)

                                           North America Healthcare Contract Research Organizations (CRO) Services Market, By Country, 2019 (%)

The report segments North America Healthcare Contract Research Organizations (CRO) Services Market as follows:

North America Healthcare Contract Research Organizations (CRO) Services Market – By Service Type

  • Early Phase Development
  • Laboratory Services
  • Consulting Services
  • Clinical Research Services

North America Healthcare Contract Research Organizations (CRO) Services Market – By Therapeutic Indication

  • Oncology
  • Infectious Diseases
  • Respiratory Diseases
  • Cardiovascular Diseases
  • Neurological Disorders
  • Others

North America Healthcare Contract Research Organizations (CRO) Services Market – By End-User

  • Medical Device Companies
  • Pharmaceutical and Biopharmaceutical Companies
  • Others (Academic Institutes)

North America Healthcare Contract Research Organizations (CRO) Services Market – By Country

  • North America
    • US
    • Canada
    • Mexico
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876

Download Free PDF Brochure